Siena Biotech has extended its license of Bioalma’s knowledge mining system, AKS2 (almaKnowledgeServer), distributed by Active Motif.
AKS2 provides a rapid way for researchers to explore information in published literature together with drug, symptom and biomedical results from Siena’s comprehensive proteomics platform.
‘The newly designed AKS2 will support our disease-based research,’ said Dr Georg C Terstappen, vice president of discovery research at Siena Biotech. ‘We have been working with Bioalma for some time now and the new AKS2 will help us extract knowledge from the data generated in our high-throughput experiments.’
